Adamas Pharmaceuticals Inc 4
4 · Adamas Pharmaceuticals Inc · Filed Jul 10, 2017
Insider Transaction Report
Form 4
MERRIWEATHER ALFRED G
Chief Financial Officer
Transactions
- Award
Common Stock
2017-07-10+18,750→ 18,750 total - Award
Stock Option (Right to Buy)
2017-07-10+112,500→ 112,500 totalExercise: $16.98Exp: 2027-07-09→ Common Stock (112,500 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest 1/4th on each of September 20, 2018, September 20, 2019, September 20, 2020 and September 20, 2021.
- [F2]The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option shall vest on June 29, 2018, and the remaining shares will vest in equal monthly installments over the next 36 months.